The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib/II study of the CD123-targeting antibody-drug conjugate IMGN632 as monotherapy or in combination with venetoclax and/or azacitidine for patients with CD123-positive acute myeloid leukemia.
 
Naval Guastad Daver
Honoraria - Abbvie; Astellas Pharma; Bristol-Myers Squibb; Immunogen; Incyte; Jazz Pharmaceuticals; Novartis; Otsuka; Pfizer
Consulting or Advisory Role - Abbvie; Agios; Astellas Pharma; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Pfizer
Research Funding - Abbvie; Astellas Pharma; Bristol-Myers Squibb; Daiichi Sankyo; Genentech; Immunogen; Nohla Therapeutics; Pfizer; Servier
 
Eunice S. Wang
Consulting or Advisory Role - Abbvie; Agios; Amgen; Astellas Pharma; Celyad; Daiichi Sankyo; Jazz Pharmaceuticals; Kite/Gilead; Kura Oncology; Macrogenics; Pfizer; PTC Therapeutics; Stemline Therapeutics
Speakers' Bureau - Jazz Pharmaceuticals; Stemline Therapeutics
 
Kendra L Sweet
Leadership - Immtech (I)
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Novartis; Stemline Therapeutics; Takeda
Research Funding - Incyte (Inst)
 
Pau Montesinos
Consulting or Advisory Role - Abbvie; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Pfizer; Roche; Shire
Speakers' Bureau - Celgene; Daiichi Sankyo; Otsuka
Research Funding - Celgene (Inst); Janssen-Cilag (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen
 
Harry Paul Erba
Consulting or Advisory Role - Agios; Amgen; Astellas Pharma; Celgene; Daiichi Sankyo; Glycomimetics; Immunogen; Incyte; Jazz Pharmaceuticals; Macrogenics; Novartis; Pfizer; Seagen
Speakers' Bureau - Agios; Celgene; Incyte; Jazz Pharmaceuticals; Novartis
Research Funding - Abbvie
Other Relationship - Celgene; Glycomimetics
(OPTIONAL) Uncompensated Relationships - Daiichi Sankyo
 
Daniel J. DeAngelo
Consulting or Advisory Role - Amgen; Blueprint Medicines; Bristol-Myers Squibb; Celgene; Immunogen; Incyte; Novartis; Pfizer; takeda
Research Funding - Abbvie (Inst); Blueprint Medicines (Inst); glycomimetics (Inst); Novartis (Inst)
 
Callum Mortimer Sloss
Employment - ImmunoGen
 
Jiuzhou Wang
Employment - ImmunoGen
 
Kara E Malcolm
Employment - ImmunoGen
 
Patrick A Zweidler-McKay
Employment - Immunogen
Stock and Other Ownership Interests - Immunogen
Patents, Royalties, Other Intellectual Property - Patent applications submitted, no royalties